EMA shortages Shortage resolved Medicine shortages
Rybelsus — supply shortage (shortage resolved)
Published by European Medicines Agency:
Summary
Supply shortage
Medicine
Rybelsus
- Category
- Medicine shortages
- Product type
- Human medicine
- Active substance (INN): semaglutide
- Therapeutic area: Diabetes Mellitus, Type 2
- Pharmaceutical forms affected: Tablet
- Strengths affected: 3 mg;7 mg;14 mg
- Last updated: 22/01/2024
Measures and alternatives
- Availability of alternatives: Yes
Source: EMA — medicine shortages — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗